The role of cetuximab in the treatment of patients with squamous cell carcinoma of the head and neck: resolution of the Expert Council

The role of cetuximab in the treatment of patients with squamous cell carcinoma of the head and neck: resolution of the Expert Council

.

Saved in:

Bibliographic Details
Format:	Article
Language:	Russian
Published:	ABV-press 2019-01-01
Series:	Опухоли головы и шеи
Online Access:	https://ogsh.abvpress.ru/jour/article/view/378
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

Practical Consensus Guidelines on the Use of Cetuximab in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Purvish M. Parikh, et al.
Published: (2025-01-01)

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice
by: A. I. Stukan, et al.
Published: (2024-06-01)

Clinical significance of peripheral T-cell repertoire in head and neck squamous cell carcinoma treated with cetuximab and nivolumab
by: Xuefeng Wang, et al.
Published: (2025-03-01)

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma
by: Chaeyeon Kim, et al.
Published: (2025-03-01)

The resolution of the Expert Council ”Possibilities of risk modification in patients with oncological diseases of the head and neck organs”
by: A. V. Rozanov, et al.
Published: (2024-08-01)

Targeted siRNA Delivery Using Cetuximab‐Conjugated Starch for Epidermal Growth Factor Receptor‐Driven Head and Neck Squamous Cell Carcinoma
by: Chen Benafsha, et al.
Published: (2025-07-01)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

Causal role of immune cells in head and neck squamous cell carcinoma
by: Panshu Xu, et al.
Published: (2025-03-01)

Cetuximab and Paclitaxel Drug Response in Head and Neck Tumor Stem Cells
by: Vilson Serafim Júnior, et al.
Published: (2025-02-01)

Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer
by: Anita Ramesh
Published: (2025-07-01)

OPTIMAL TREATMENT STRATEGY FOR PATIENTS WITH PROGRESSIVE SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
by: L. V. Bolotina, et al.
Published: (2019-09-01)

Recent advances of photodiagnosis and treatment for head and neck squamous cell carcinoma
by: Yining Zhang, et al.
Published: (2025-02-01)

Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer
by: Kumar Prabhash, et al.
Published: (2025-07-01)

Natural killer cell in the development and treatment of head and neck squamous cell carcinoma
by: Lu-Ming WANG, et al.
Published: (2021-02-01)

Clinicopathological profile of head and neck squamous cell carcinoma
by: Senjuti Dasgupta, et al.
Published: (2019-01-01)

Molecular features of head and neck squamous cell carcinoma
by: G. V. Kakurina, et al.
Published: (2018-09-01)

Role of E-cadherin and β-catenin in head and neck squamous cell carcinoma
by: A. A. Petrova, et al.
Published: (2024-01-01)

THE ROLE OF PSMA PET/CT IN THE CHARACTERIZATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
by: Hadila da Silva Veras Sousa, et al.
Published: (2025-05-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy
by: Hong-Xia Li, et al.
Published: (2024-11-01)

EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
by: Jiefu Zhou, et al.
Published: (2025-03-01)

Prospects of epigenetic therapy of head and neck squamous cell carcinoma
by: R. N. Mustafin
Published: (2023-09-01)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
by: Muzaffar Shah-Khan, et al.
Published: (2013-03-01)

Risk Factors and Diagnosis of Head and Neck Squamous Cell Carcinoma
by: Yussy Afriani Dewi, et al.
Published: (2024-12-01)

EXPRESSION PROFILE OF MICRORNAS IN SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: Yu. A. Veryaskina, et al.
Published: (2016-02-01)

RESOLUTION ON THE RESULTS OF THE EXPERT COUNCIL
by: article Editorial
Published: (2024-02-01)

Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
by: Aidan G. Major, et al.
Published: (2013-01-01)

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: G. V. Kakurina, et al.
Published: (2016-02-01)

Nivolumab resistance in head and neck squamous cell carcinoma patients and future perspectives
by: Karolina Buchajska, et al.
Published: (2025-04-01)

Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma
by: Bryce Hambach, et al.
Published: (2025-07-01)

Outcomes in patients with head and neck squamous cell carcinoma with exclusively surgical resection
by: Daniel Naves Araujo Teixeira, et al.
Published: (2025-09-01)

The effect of second hand smoke in patients with squamous cell carcinoma of the head and neck
by: Sherif Idris, et al.
Published: (2019-07-01)

Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
by: A. M. Mudunov, et al.
Published: (2019-04-01)

Radiodosiomics Prediction of Treatment Failures Prior to Chemoradiotherapy in Head-and-Neck Squamous Cell Carcinoma
by: Hidemi Kamezawa, et al.
Published: (2025-06-01)

Optical metabolic imaging of treatment response in human head and neck squamous cell carcinoma.
by: Amy T Shah, et al.
Published: (2014-01-01)

Strategies for Anticancer Treatment in p53-Mutated Head and Neck Squamous Cell Carcinoma
by: Bi-He Cai, et al.
Published: (2025-05-01)

Expert consensus on the combination of anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma (2025 edition)
by: XUE Liqiong, XU Tingting, GUO Ye, HU Chaosu
Published: (2025-05-01)

Combination of concurrent targeted and immune-therapy with nivolumab and cetuximab: new perspectives for squamous cell carcinoma treatment
by: A. M. Mudunov, et al.
Published: (2020-11-01)

Contrast-enhanced ultrasound in the diagnosis of head and neck squamous cell carcinoma
by: G. F. Allakhverdieva, et al.
Published: (2019-04-01)